Control Resonant, the new game from the Finnish studio Remedy Entertainment, was cracked a day before its release. Parts of the piracy scene responded by telling people to buy it.
The game launched worldwide on 24 September. A working crack appeared on 23 September, after preload files went live, circulating first through unverified mirrors before established scene groups issued their own versions.
It is not clear whether the crack affects online features or only single-player play. The protection is a familiar stack, similar to that used on older Remedy titles.
What followed was not the usual reaction. On piracy forums, users actively discouraged others from taking the copy, urging anyone who could afford the game to buy it instead and keep the studio going.
Practical objections were raised alongside the commercial ones. Pre-launch builds lack day-one patches and driver updates, and unverified distributions carry risks of their own.
The commercial case is a matter of public record. Remedy's half-year report put revenue for January to June 2026 at €23.3m, down 23.1% from €30.3m a year earlier.
The second quarter was sharper still. Revenue fell 40.0% to €10.2m from €16.9m, EBITDA was minus €2.4m against a positive €4.2m, and the operating result was minus €3.9m.
Within that, game sales and royalties came to €3.8m against €9.5m a year earlier. Development fees, from the Max Payne 1&2 remake and from Control Resonant itself, were €6.4m.
Remedy has a long-standing pattern of critically admired games that underperform at launch. Alan Wake 2, its most acclaimed release, has still not recovered its budget.
Something has gone wrong with the category. Piracy is defined by the absence of a purchasing decision, and what has occurred here is a purchasing decision, reached collectively, by people holding a free copy.
This newspaper notes the procedure carefully. The scene acquired the product, verified it, reviewed the vendor's half-year financial statements and issued a recommendation to the market. Three of those four steps are what an analyst does.
The recommendation is a buy. It was arrived at without a licence, without a contract, and without any prospect of commission.
The Department of Unnecessary Research has struggled to establish what to call the result. A copy that exists, can be distributed, and is being withheld on the grounds that the manufacturer needs the money is not a pirated copy. It is inventory under embargo.
Remedy therefore enters the most important launch week in its history with a distribution network it did not build, cannot audit and has never paid: global reach, no marketing budget, and a sales force whose entire pitch this quarter is that the game is worth the money.
The crack works perfectly. Its holders have read the accounts and decided not to use it.